These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8676172)

  • 1. Metabolic risk factors for cardiovascular disease in a working population: a retrospective cohort study.
    Gumbiner B; Andresen EM; Hearne FT; Michaelson TE; Bryson M; Lednar WM; Cass R
    J Clin Epidemiol; 1996 Mar; 49(3):267-71. PubMed ID: 8676172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic alterations predictive of cardiovascular disease risk in the Québec population.
    Scarsella C; Alméras N; Mauriège P; Blanchet C; Sauvé L; Dewailly E; Bergeron J; Després JP
    Can J Cardiol; 2003 Jan; 19(1):51-7. PubMed ID: 12571695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring clinical predictors of cardiovascular disease in a central Australian Aboriginal cohort.
    Luke JN; Brown AD; Brazionis L; O'Dea K; Best JD; McDermott RA; Wang Z; Wang Z; Rowley KG
    Eur J Prev Cardiol; 2013 Apr; 20(2):246-53. PubMed ID: 22345691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
    Bonora E; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Cacciatori V; Santi L; Targher G; Bonadonna R; Muggeo M
    Diabetes Care; 2002 Jul; 25(7):1135-41. PubMed ID: 12087010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: A population-based prospective study.
    Ramezankhani A; Azizi F; Hadaegh F; Eskandari F
    Atherosclerosis; 2017 Aug; 263():249-256. PubMed ID: 28683364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey.
    Oladapo OO; Salako L; Sodiq O; Shoyinka K; Adedapo K; Falase AO
    Cardiovasc J Afr; 2010; 21(1):26-31. PubMed ID: 20224842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.
    Hanley AJ; Williams K; Stern MP; Haffner SM
    Diabetes Care; 2002 Jul; 25(7):1177-84. PubMed ID: 12087016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of new criterion of glucose level on the prevalence of impaired fasting glucose and risk of ischemic cardiovascular diseases].
    Wang W; Zhao D; Sun JY; Liu J; Qin LP; Wu ZS
    Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):20-4. PubMed ID: 17331382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist circumference as a screening tool for the identification of adolescents with the metabolic syndrome phenotype.
    Bitsori M; Linardakis M; Tabakaki M; Kafatos A
    Int J Pediatr Obes; 2009; 4(4):325-31. PubMed ID: 19922048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between metabolic diseases and all-cause and cardiovascular death in an elderly male population during a 15-year follow-up].
    Sun B; Shao Y; Li J; Tian H; Li C
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):913-8. PubMed ID: 24854911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol consumption, metabolic cardiovascular risk factors and hypertension in women.
    Nanchahal K; Ashton WD; Wood DA
    Int J Epidemiol; 2000 Feb; 29(1):57-64. PubMed ID: 10750604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
    Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
    J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study.
    Rabani S; Sardarinia M; Akbarpour S; Azizi F; Khalili D; Hadaegh F
    PLoS One; 2018; 13(5):e0195543. PubMed ID: 29768511
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.